Cargando…

Children are protected against SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Dimeglio, Chloé, Mansuy, Jean-Michel, Charpentier, Sandrine, Claudet, Isabelle, Izopet, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237367/ https://www.ncbi.nlm.nih.gov/pubmed/32454427 http://dx.doi.org/10.1016/j.jcv.2020.104451

Ejemplares similares

Quantifying the impact of public health protection measures on the spread of SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Estimating the impact of public health strategies on the spread of SARS‐CoV‐2: Epidemiological modelling for Toulouse, France
por: Dimeglio, Chloé, et al.
Publicado: (2021)

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
por: Dimeglio, Chloé, et al.
Publicado: (2020)

Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Antibody titers and protection against a SARS-CoV-2 infection
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers
por: Migueres, Marion, et al.
Publicado: (2020)

Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant
por: Migueres, Marion, et al.
Publicado: (2022)

Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load
por: Migueres, Marion, et al.
Publicado: (2022)

The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study
por: Migueres, Marion, et al.
Publicado: (2021)

Influence of age on the spread of SARS-CoV-2 variant B.1.1.7
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
por: Chapuy-Regaud, Sabine, et al.
Publicado: (2021)

Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Omicron Wave SARS-CoV-2 Diagnosis: Evaluation of Saliva, Anterior Nasal, and Nasopharyngeal Swab Samples
por: Migueres, Marion, et al.
Publicado: (2022)

One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Chikungunya in the Caribbean—Threat for Europe
por: Mansuy, Jean-Michel, et al.
Publicado: (2014)

Weaker Effects of the Fourth Dose of BNT162b2 SARS-CoV-2 Vaccine on the Elderly Human Population
por: Dimeglio, Chloé, et al.
Publicado: (2023)

Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens
por: Trémeaux, Pauline, et al.
Publicado: (2020)

Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein
por: Abravanel, Florence, et al.
Publicado: (2020)

Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants
por: Migueres, M., et al.
Publicado: (2021)

Whole‐genome sequencing of SARS‐CoV‐2: Comparison of target capture and amplicon single molecule real‐time sequencing protocols
por: Nicot, Florence, et al.
Publicado: (2022)

Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
por: Vellas, Camille, et al.
Publicado: (2022)

Evaluation of a polymerase chain reaction–electrospray ionization time-of-flight mass spectrometry for the detection and subtyping of influenza viruses in respiratory specimens
por: Mengelle, Catherine, et al.
Publicado: (2013)

High SARS-CoV-2 IgG seroprevalence among pregnant Cameroun women 14 months after the beginning of the pandemic
por: Mansuy, J.-M., et al.
Publicado: (2022)

Will the latest wave of the COVID‐19 pandemic be an ecological disaster? There is an urgent need to replace plastic by ecologically virtuous materials
por: Mansuy, Jean‐Michel, et al.
Publicado: (2022)

ABO Blood Group Incompatibility Protects Against SARS-CoV-2 Transmission
por: Boukhari, Rachida, et al.
Publicado: (2022)

Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
por: Kamar, Nassim, et al.
Publicado: (2021)

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab
por: Vellas, Camille, et al.
Publicado: (2022)

COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination?
por: Mansuy, Jean Michel, et al.
Publicado: (2021)

The use of a multiplex real-time PCR assay for diagnosing acute respiratory viral infections in children attending an emergency unit
por: Mengelle, C., et al.
Publicado: (2014)

HCQ use not protective against SARS-CoV-2
por: Onuora, Sarah
Publicado: (2020)

Cross-viral protection against SARS-CoV-2?
por: Reed, Sophie G.
Publicado: (2020)

IL-13 Protects against SARS-CoV-2?
por: Peebles, R. Stokes
Publicado: (2022)

Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients
por: Kamar, Nassim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6n3kupc31a1tp27t9ea7shn8rq